Victoria Schauf

1.2k total citations
38 papers, 895 citations indexed

About

Victoria Schauf is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Victoria Schauf has authored 38 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Victoria Schauf's work include Leprosy Research and Treatment (7 papers), Infectious Diseases and Tuberculosis (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Victoria Schauf is often cited by papers focused on Leprosy Research and Treatment (7 papers), Infectious Diseases and Tuberculosis (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Victoria Schauf collaborates with scholars based in United States and Thailand. Victoria Schauf's co-authors include Gilla Kaplan, Sanit Makonkawkeyoon, André L. Moreira, Kenrad E. Nelson, Louise J. Riff, Anthony J. Strelkauskas, Audra Deveikis, Barry S. Wilson, Leonard Chess and Stuart F. Schlossman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Neurology.

In The Last Decade

Victoria Schauf

36 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victoria Schauf United States 16 360 312 241 128 116 38 895
V. Faber Denmark 18 374 1.0× 191 0.6× 213 0.9× 38 0.3× 61 0.5× 37 914
Are Næss Norway 16 402 1.1× 154 0.5× 233 1.0× 68 0.5× 77 0.7× 55 888
E. B. Helm Germany 16 414 1.1× 597 1.9× 328 1.4× 78 0.6× 46 0.4× 52 1.3k
Jean Henrik Braconier Sweden 20 474 1.3× 110 0.4× 525 2.2× 72 0.6× 68 0.6× 53 1.2k
Robert C. Tam United States 17 477 1.3× 210 0.7× 339 1.4× 47 0.4× 75 0.6× 28 1.2k
R M Ferguson United States 16 197 0.5× 149 0.5× 269 1.1× 230 1.8× 447 3.9× 59 1.2k
Bonnie J. Ank United States 16 181 0.5× 149 0.5× 346 1.4× 92 0.7× 39 0.3× 37 741
Rosa M. Andrade United States 17 495 1.4× 177 0.6× 457 1.9× 179 1.4× 58 0.5× 25 1.5k
D. W. Wara United States 18 403 1.1× 156 0.5× 246 1.0× 79 0.6× 46 0.4× 27 1.0k
J.C.M. Shastry India 19 348 1.0× 352 1.1× 80 0.3× 76 0.6× 174 1.5× 64 964

Countries citing papers authored by Victoria Schauf

Since Specialization
Citations

This map shows the geographic impact of Victoria Schauf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Schauf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Schauf more than expected).

Fields of papers citing papers by Victoria Schauf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Schauf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Schauf. The network helps show where Victoria Schauf may publish in the future.

Co-authorship network of co-authors of Victoria Schauf

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Schauf. A scholar is included among the top collaborators of Victoria Schauf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Schauf. Victoria Schauf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirsten, W. H., Victoria Schauf, & J. L. McCoy. (2015). Properties of a Murine Sarcoma Virus1. Proceedings of the International Symposium on Comparative Leukemia Research. 246–249. 11 indexed citations
2.
Schauf, Victoria, et al.. (2009). Decreased cell-mediated immunity to respiratory syncytial virus in multiple sclerosis. Acta Neurologica Scandinavica. 64(6). 383–393.
3.
Makonkawkeyoon, Sanit, et al.. (1993). Thalidomide inhibits the replication of human immunodeficiency virus type 1.. Proceedings of the National Academy of Sciences. 90(13). 5974–5978. 184 indexed citations
4.
Schauf, Victoria, William N. Rom, Kendall A. Smith, et al.. (1993). Cytokine Gene Activation and Modified Responsiveness to Interleukin-2 in the Blood of Tuberculosis Patients. The Journal of Infectious Diseases. 168(4). 1056–1059. 73 indexed citations
5.
Schauf, Victoria, et al.. (1991). Sensitization in vitro of human peripheral blood mononuclear cells to phenolic glycolipid 1 of Mycobacterium leprae in liposomes. Cellular Immunology. 137(1). 81–87. 1 indexed citations
6.
Miller, Paul S., Victoria Schauf, & Richard J. Salo. (1990). Enhanced Killing of Group B Streptococci In Vitro by Penicillin and Opsonophagocytosis with Intravenous Immunoglobulin. The Journal of Infectious Diseases. 161(6). 1225–1230. 6 indexed citations
7.
Wagener, Diane K., Victoria Schauf, Kenrad E. Nelson, et al.. (1988). Segregation analysis of leprosy in families of northern Thailand. Genetic Epidemiology. 5(2). 95–105. 23 indexed citations
8.
Schauf, Victoria, et al.. (1987). HUMAN IMMUNIZATION IN VITRO. Pediatric Research. 21(4). 317A–317A. 1 indexed citations
9.
Tung, Kenneth S. K., Edith T. Umland, Pini Matzner, et al.. (1987). Soluble serum interleukin 2 receptor levels in leprosy patients.. PubMed. 69(1). 10–5. 31 indexed citations
10.
Schauf, Victoria, Sharon Ryan, David M. Scollard, et al.. (1985). Leprosy associated with HLA‐DR2 and DQwl in the population of northern Thailand. Tissue Antigens. 26(4). 243–247. 48 indexed citations
11.
Tolpin, Mark D., et al.. (1985). Penicillin Prophylaxis and the Neonatal Microbial Flora. The Journal of Infectious Diseases. 152(5). 1070–1073. 12 indexed citations
12.
Schauf, Victoria, et al.. (1983). Chloramphenicol kills Haemophilus influenzae more rapidly than does ampicillin or cefamandole. Antimicrobial Agents and Chemotherapy. 23(3). 364–368. 8 indexed citations
13.
Bullock, Ward E., Susan R. Watson, Kenrad E. Nelson, et al.. (1982). Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy.. PubMed. 49(1). 105–14. 35 indexed citations
14.
Harris, Vivian J., et al.. (1979). Fatal Tuberculosis in Young Children. PEDIATRICS. 63(6). 912–914. 8 indexed citations
15.
Schauf, C. L., et al.. (1978). Complement‐dependent serum. Neurology. 28(5). 426–426. 21 indexed citations
16.
Schauf, C. L., et al.. (1977). Lymphocyte subpopulations in multiple sclerosis. Neurology. 27(9). 822–822. 7 indexed citations
17.
Deveikis, Audra, et al.. (1977). Antimicrobial Therapy of Experimental Group B Streptococcal Infection in Mice. Antimicrobial Agents and Chemotherapy. 11(5). 817–820. 27 indexed citations
18.
Schauf, Victoria, et al.. (1976). Antibiotic-killing kinetics of group B streptococci. The Journal of Pediatrics. 89(2). 194–198. 64 indexed citations
19.
Schauf, Victoria & Sandra Panem. (1976). Expression of murine oncornavirus proteins in synchronized cells. Virology. 71(2). 619–623. 5 indexed citations
20.
Schauf, Victoria, et al.. (1975). Immunization of Rous Sarcoma Virus-Inoculated Marmosets With BCG and Transformed Allogeneic Cells2. JNCI Journal of the National Cancer Institute. 54(1). 151–155. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Faber Breakdown of academic impact, for papers by Are Næss Breakdown of academic impact, for papers by E. B. Helm Breakdown of academic impact, for papers by Jean Henrik Braconier Breakdown of academic impact, for papers by Robert C. Tam Breakdown of academic impact, for papers by R M Ferguson Breakdown of academic impact, for papers by Bonnie J. Ank Breakdown of academic impact, for papers by Rosa M. Andrade Breakdown of academic impact, for papers by D. W. Wara Breakdown of academic impact, for papers by J.C.M. Shastry
Rankless by CCL
2026